Skip to main content
. 2018 Jun 18;3(3):140–146. doi: 10.1136/svn-2018-000158

Table 3.

Rates of disabling or fatal stroke and withdrawal or lost to follow-up

SAMMPRIS trial Disabling or fatal stroke within 30 days Disabling or fatal stroke beyond 30 days Rate of withdrawal or lost to follow-up
Medical group
(n=227)
4 (1.8%) 14 (6.2%) 24 (10.5%)
Stenting group
(n=224)
14 (6.2%) 5 (2.2%) 10 (4.4%)